Manufacturers Life Insurance Company, The Provention Bio, Inc. Transaction History

Manufacturers Life Insurance Company, The

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	SELL	$0.0 - $24.98 $0 - $618,005	-24,740 Closed	0 $0
Q4 2022 Aug 11, 2023	BUY	$4.52 - $10.57 $1,600 - $3,741	354 Added 1.45%	24,740 $261,000
Q4 2022 Feb 13, 2023	BUY	$4.52 - $10.57 $1,600 - $3,741	354 Added 1.45%	24,740 $261,000
Q3 2022 Aug 11, 2023	SELL	$3.43 - $5.62 $3,388 - $5,552	-988 Reduced 3.89%	24,386 $109,000
Q3 2022 Nov 03, 2022	SELL	$3.43 - $5.62 $3,388 - $5,552	-988 Reduced 3.89%	24,386 $110,000

Q2 2022 Aug 11, 2023	BUY	$3.65 - $7.3 $3,160 - $6,321	866 Added 3.53%	25,374 $101,000
Q2 2022 Aug 15, 2022	BUY	$3.65 - $7.3 $3,160 - $6,321	866 Added 3.53%	25,374 $101,000
Q1 2022 Aug 11, 2023	SELL	$3.4 - $7.88 $788 - $1,828	-232 Reduced 0.94%	24,508 $179,000
Q1 2022 May 20, 2022	SELL	$3.4 - $7.88 $25,602 - $59,336	-7,530 Reduced 23.5%	24,508 $179,000
Q4 2021 Feb 16, 2022	SELL	$5.59 - $7.39 $7,283 - $9,629	-1,303 Reduced 3.91%	32,038 $180,000
Q3 2021 Nov 12, 2021	SELL	$5.66 - $8.33 $7,284 - $10,720	-1,287 Reduced 3.72%	33,341 $213,000
Q2 2021 Aug 12, 2021	BUY	$6.71 - $11.04 $23,988 - $39,468	3,575 Added 11.51%	34,628 $292,000
Q1 2021 May 03, 2021	BUY	$10.12 - $19.45 $22,233 - $42,731	2,197 Added 7.61%	31,053 $326,000
Q4 2020 Feb 12, 2021	BUY	$11.79 - $18.94 $18,958 - $30,455	1,608 Added 5.9%	28,856 $489,000
Q3 2020 Nov 09, 2020	BUY	$10.34 - $15.2 $18,084 - $26,584	1,749 Added 6.86%	27,248 $350,000
Q2 2020 Aug 10, 2020	BUY	$7.81 - $17.0 $199,147 - $433,483	25,499 New	25,499 $365,000

170K

Ticker PRVB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 81,549,904
Description
Provention Bio, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics and solutions to intercept and prevent immune-mediated diseases. Its products candidates include PRV-031 teplizumab and monoclonal antibodies (mAb) that is in Phase III clinical trial for the interception of type one...

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.